Unnamed stage
$7.2m
Contraline erects $7.2M for contraceptive implants for men
Male contraceptive startup Contraline has secured $7.2 million in a GV-led round to progress first-in-human trials of its ADAM hydrogel implant, with initial patients treated in Australia.